These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1975081)

  • 1. The effects of 5-HT1B characterizing agents in the mouse elevated plus-maze.
    Benjamin D; Lal H; Meyerson LR
    Life Sci; 1990; 47(3):195-203. PubMed ID: 1975081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A discriminative stimulus produced by 1-(3-chlorophenyl)-piperazine (mCPP) as a putative animal model of anxiety.
    Wallis CJ; Lal H
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Apr; 22(3):547-65. PubMed ID: 9612850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
    Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
    Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of GABA-ergic and serotonergic systems in the anxiolytic-like mechanism of action of a 5-HT-moduline antagonist in the mouse elevated plus maze.
    Clénet F; Hascoët M; Fillion G; Galons H; Bourin M
    Behav Brain Res; 2005 Mar; 158(2):339-48. PubMed ID: 15698901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents.
    Lalonde R; Strazielle C
    Fundam Clin Pharmacol; 2010 Jun; 24(3):365-76. PubMed ID: 19735300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP.
    Rodgers RJ; Cole JC; Cobain MR; Daly P; Doran PJ; Eells JR; Wallis P
    Behav Pharmacol; 1992 Dec; 3(6):621-634. PubMed ID: 11224163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of pentylenetetrazol, chlordiazepoxide and caffeine in rats tested in the elevated plus-maze depend on the experimental illumination.
    Garcia AM; Cardenas FP; Morato S
    Behav Brain Res; 2011 Feb; 217(1):171-7. PubMed ID: 20933019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice.
    Wiley JL; Cristello AF; Balster RL
    Eur J Pharmacol; 1995 Dec; 294(1):101-7. PubMed ID: 8788421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropharmacological evaluation of a novel 5-HT3 receptor antagonist (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl) methanone (6g) on lipopolysaccharide-induced anxiety models in mice.
    Bhatt S; Mahesh R; Devadoss T; Jindal A
    J Basic Clin Physiol Pharmacol; 2017 Mar; 28(2):101-106. PubMed ID: 27664773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5HT(1A) and 5HT(1B) receptors of medial prefrontal cortex modulate anxiogenic-like behaviors in rats.
    Solati J; Salari AA; Bakhtiari A
    Neurosci Lett; 2011 Oct; 504(3):325-9. PubMed ID: 21982809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABA and 5-HT systems are implicated in the anxiolytic-like effect of spinosin in mice.
    Liu J; Zhai WM; Yang YX; Shi JL; Liu QT; Liu GL; Fang N; Li J; Guo JY
    Pharmacol Biochem Behav; 2015 Jan; 128():41-9. PubMed ID: 25449359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
    Prather PL; Rezazadeh SM; Lane JD; Rowan GA; Hooper ML; Lytle DA; Emmett-Oglesby MW; Lal H
    J Pharmacol Exp Ther; 1993 Feb; 264(2):622-30. PubMed ID: 8094750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrous oxide anxiolytic effect in mice in the elevated plus maze: mediation by benzodiazepine receptors.
    Emmanouil DE; Johnson CH; Quock RM
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):167-72. PubMed ID: 7862891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
    dos Reis LM; Canto-de-Souza A
    Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat.
    Bervoets K; Millan MJ; Colpaert FC
    Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of (Z)-3-hexenol, a major component of green odor, on anxiety-related behavior of the mouse in an elevated plus-maze test and biogenic amines and their metabolites in the brain.
    Tokumo K; Tamura N; Hirai T; Nishio H
    Behav Brain Res; 2006 Jan; 166(2):247-52. PubMed ID: 16214236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the rat exploratory behavior in the elevated plus-maze with Markov chains.
    Tejada J; Bosco GG; Morato S; Roque AC
    J Neurosci Methods; 2010 Nov; 193(2):288-95. PubMed ID: 20869398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated zero maze: a paradigm to evaluate antianxiety effects of drugs.
    Kulkarni SK; Singh K; Bishnoi M
    Methods Find Exp Clin Pharmacol; 2007 Jun; 29(5):343-8. PubMed ID: 17805436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar anxiolytic-like effects following intra-amygdala infusions of benzodiazepine receptor agonist and antagonist: evidence for the release of an endogenous benzodiazepine inverse agonist in mice exposed to elevated plus-maze test.
    Barbalho CA; Nunes-de-Souza RL; Canto-de-Souza A
    Brain Res; 2009 Apr; 1267():65-76. PubMed ID: 19268657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu-opioid receptor knockout mice are more sensitive to chlordiazepoxide-induced anxiolytic behavior.
    Wang KC; Lee YJ; Fan LW; Yang PP; Tao PL; Ho IK; Tien LT
    Brain Res Bull; 2013 Jan; 90():137-41. PubMed ID: 23142328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.